Q4 2025 Holdings
Filed 2026-02-17 | 33 holdings | $236.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Relmada Therapeutics Inc(RLMD) | COM | 75955J402 | $32.4M | 6,700,000 | 13.7% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $27.7M | 780,000 | 11.7% |
| Maze Therapeutics Inc(MAZE) | COM | 578784100 | $20.3M | 490,000 | 8.6% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $19.6M | 145,000 | 8.3% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $11.3M | 700,000 | 4.8% |
| Palisade BIO Inc(PALI) | COM | 696389402 | $10.6M | 4,500,000 | 4.5% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $8.7M | 350,000 | 3.7% |
| Inhibikase Therapeutics Inc(IKT) | COM NEW | 45719W205 | $8.7M | 4,225,000 | 3.7% |
| Kodiak Sciences Inc(KOD) | COM | 50015M109 | $8.2M | 291,710 | 3.5% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $7.7M | 190,000 | 3.3% |
| Arrivent Biopharma Inc(AVBP)Call | COM | 04272N102 | $6.8M | 338,000 | 2.9% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $6.6M | 80,000 | 2.8% |
| Upstream BIO Inc(UPB) | COM | 91678A107 | $6.3M | 230,650 | 2.7% |
| Spruce Biosciences Inc(SPRB) | COM NEW | 85209E208 | $6.1M | 70,000 | 2.6% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $4.7M | 105,551 | 2.0% |
| DBV Technologies S A(DBVT) | SPONSORED ADS | 23306J309 | $4.6M | 240,000 | 1.9% |
| Cybin Inc(HELP) | COM NEW | 23256X407 | $4.3M | 525,000 | 1.8% |
| Lipocine Inc New(LPCN) | COM NEW | 53630X203 | $4.3M | 530,000 | 1.8% |
| Belite BIO Inc(BLTE) | SPONSORED ADS | 07782B104 | $4.2M | 26,000 | 1.8% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $4.0M | 315,000 | 1.7% |
| Eupraxia Pharmaceuticals Inc(EPRX) | COM | 29842P105 | $3.8M | 500,000 | 1.6% |
| Ventyx Biosciences Inc(VTYX) | COM | 92332V107 | $3.7M | 410,000 | 1.6% |
| Nextcure Inc(NXTC) | COM NEW | 65343E207 | $3.4M | 236,966 | 1.4% |
| Vera Therapeutics Inc(VERA)Call | CL A | 92337R101 | $3.0M | 60,000 | 1.3% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $3.0M | 175,000 | 1.3% |
| Pasithea Therapeutics Corp(KTTA) | COM NEW | 70261F202 | $2.7M | 2,100,000 | 1.1% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $2.7M | 388,287 | 1.1% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $2.4M | 130,000 | 1.0% |
| Inventiva SA(IVA) | ADS | 46124U107 | $1.4M | 300,000 | 0.6% |
| Zenas Biopharma Inc(ZBIO)Call | COM | 98937L105 | $1.3M | 36,000 | 0.6% |
| Traws Pharma Inc(TRAW) | COM NEW | 68232V884 | $806.3K | 713,540 | 0.3% |
| Intellia Therapeutics Inc(NTLA)Call | COM | 45826J105 | $728.2K | 81,000 | 0.3% |
| Climb BIO Inc(CLYM) | COM | 28658R106 | $400.0K | 100,000 | 0.2% |